Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02674347 · ClinicalTrials.gov registry record · Phase 1
MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT02674347 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 21 participants.
The verdict
NCT02674347, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Study to evaluate the safety and tolerability of multiple escalating doses of intravenous (IV) Zidebactam in healthy adult human subjects.
Interventions
- DRUG Placebo
- DRUG 3 g or 6 g Zidebactam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02674347
The ClinicalTrials.gov registry entry for NCT02674347 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wockhardt, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02674347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02674347 about?
NCT02674347 is a clinical study titled "MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults". Study to evaluate the safety and tolerability of multiple escalating doses of intravenous (IV) Zidebactam in healthy adult human subjects.
What is the current status of trial NCT02674347?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2016-02. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02674347?
The interventions under investigation include: Placebo (DRUG), 3 g or 6 g Zidebactam (DRUG).
Who is sponsoring clinical trial NCT02674347?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.